Navigation Links
Vermillion Reports First Quarter 2013 Results
Date:5/15/2013

A1 with current clinical practice and showing how OVA1 can greatly reduce the percentage of women who receive substandard care.  

The funding will also support two important strategic initiatives:

  • The company will migrate OVA1 to a state-of-the-art clinical testing platform commonly available around the world.  This will expand the market for the test to more laboratories and hospitals and enable licensing OVA1 in non-U.S. markets. It will require the successful execution of validation and clinical studies to support submission of a 510-K and FDA clearance. The company targets launch on this new platform by the end of 2014.
  • The company will also use the funding to accelerate the development of a next generation ovarian cancer diagnostic. This test will utilize a combination of current and novel biomarkers in a new algorithm to increase specificity and positive predictive value, while significantly reducing false positives. The company expects to announce proof of concept results during the second quarter and targets the launch of a next generation test in 2015.
  • Conference Call and Webcast
    Vermillion will hold a conference call to discuss its first quarter results later today, Wednesday, May 15, 2013 at 4:30 p.m. Eastern time. Vermillion's President and CEO Thomas McLain will host the call, followed by a question and answer period.

    Date: Wednesday, May 15, 2013
    Time: 4:30 p.m. Eastern time
    Dial-In number: 1-800-709-0218
    International: 1-212-231-2915
    Conference ID: 21656230
    Webcast: http://www.media-server.com/m/p/mo7xofgw

    The conference call will be webcast live and available for replay via the investor section of the company's website at www.vermillion.com.

    Please call the conference telephone number 5-10 minutes prior to the start time. An operator will regi
    '/>"/>

    SOURCE Vermillion, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related biology technology :

    1. Vermillion Sharpens Focus and Streamlines Operations in 2012
    2. Vermillion Reports Fourth Quarter and Full Year 2011 Results
    3. Vermillion Reports First Quarter 2012 Results
    4. Concerned Stockholders Launch Save Vermillion! Website: www.savevrml.com
    5. Vermillion to Participate in Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference on February 27, 2013
    6. Vermillion to Report Results for Fourth Quarter and Full Year 2012 on Wednesday, February 20, 2013
    7. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
    8. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
    9. Interleukin Genetics Reports Third Quarter 2011 Financial Results
    10. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
    11. Nile Therapeutics Reports 2011 Third Quarter Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/14/2014)... (PRWEB) January 14, 2014 iLab Solutions, the ... as the new Director of Product Strategy. In this role, ... as iLab sub-teams to guide in the development of iLab ... provides the maximum possible benefit to the scientific community by ...
    (Date:1/14/2014)... MD (PRWEB) January 14, 2014 ... to developing innovative information technology solutions for patients, ... health care stakeholders, announced today the signing of ... US Food and Drug Administration (FDA). This ...
    (Date:1/14/2014)... Orange, CA (PRWEB) January 14, 2014 Kerr ... a 10-minute video and additional how-to information about dual arch ... Great Restorations with Dual Arch Impressions,” the blog entry serves ... the technique and houses a step-by-step demonstration by Dr. David ...
    (Date:1/14/2014)... BioMedomics, Inc. , a Point of Care ... novel disease specific POC tests, announced today that it has ... of $690,000. The investment is from private investors and is ... of private investors has significant successful experience in early investments ...
    Breaking Biology Technology:iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2BioMedomics, Inc. Closes $690K Round of Financing 2
    ... , , , , , ... , of 139 human cancer-related genes for functional genomics research ... , , , , , ... leading academic , cancer researchers (see table below for a ...
    ... , , For 124 high-purity plasmid minipreps , , , ... , , , ... , Purification module: , QIAprep spin columns, ... 124 samples, , , ...
    ... , , , , , , For purification of ... Classic QIAGEN Plasmid Kits use gravity-flow anion-exchange tips for efficient , purification of plasmid DNA ... Features and benefits , ... Purity equivalent to that obtained by 2x CsCl-gradient centrifugation , ...
    Cached Biology Technology:Cancer siRNA Oligo Set Version 1.0 2Cancer siRNA Oligo Set Version 1.0 3Cancer siRNA Oligo Set Version 1.0 4
    (Date:7/9/2014)... Rochelle, NY, July 9, 2014Biofuels derived from the oils ... to fossil fuels. To achieve this goal, optimization of ... in open pond systems, is needed. Sapphire Energy has ... of open pond algae cultivation systems, described in ... Liebert, Inc., publishers. The article is available on the ...
    (Date:7/9/2014)... of Guelph scientist that involved fitting bumblebees with ... a neonicotinoid pesticide hampers bees, ability to forage ... a professor in Guelph,s School of Environmental Sciences, ... published July 9 in the British Ecological Society,s ... shows how long-term pesticide exposure affects individual bees, ...
    (Date:7/9/2014)... study shows that some shark species may be able to ... come with rising temperatures. , The Arctic today is best ... wasn,t always like that. Roughly 53 to 38 million years ... Arctic was more similar to a huge temperate forest with ... ancestors of tapirs, hippo-like creatures, crocodiles and giant tortoises. Much ...
    Breaking Biology News(10 mins):Controlling contamination in open algae ponds for biofuels 2Bee foraging chronically impaired by pesticide exposure: Study 2Shark teeth analysis provides detailed new look at Arctic climate change 2Shark teeth analysis provides detailed new look at Arctic climate change 3
    ... BUFFALO, N.Y. -- Among the many differences between girls ... and subjective -- to the list. , Results of a ... caffeine found that, in general, boys get a greater rush ... reported they felt that caffeine had a positive effect on ...
    ... Professor Dr. Michael Ristow,s team along with Japanese colleagues ... two independent approaches that even a low concentration of ... as well as in a model organism, the roundworm ... results in the online edition of the scientific publication ...
    ... is a growing concern. Protected areas are a instrument to ... of the parties in Nagoya (October 2010) set stringent new ... terrestrial and inland water and 10% of coastal and marine ... protected? Are they in the right place? Where should new ...
    Cached Biology News:High-caffeine-consuming boys get greater rush from caffeine than girls 2High-caffeine-consuming boys get greater rush from caffeine than girls 3Fountain of youth from the tap 2Biodiversity in danger: Which areas should be protected? 2Biodiversity in danger: Which areas should be protected? 3
    Recombinant DNA polymerase from Thermus aquaticus expressed in E. coli; 5 units/L; 1 tube of 1, 000 units enzyme/tube w/Buffer II and MgCl2...
    Taq DNA Polymerase (T. aquaticus), 4 x 250 units. For PCR and other procedures requiring DNA polymerase activity at elevated temperatures. Category: Nucleotides & Enzymes & Biochemicals, Modifying En...
    ... Gold® DNA Polymerase is a chemically modified ... chemical moiety is attached to the enzyme, ... the first ramp of thermal cycling (when ... temperatures), the enzyme is inactive. The result ...
    Taq DNA Polymerase (cloned), 250 units. Category: Nucleotides & Enzymes & Biochemicals, Modifying Enzymes, Polymerases....
    Biology Products: